Antidepressant - Articles - Page 3

Psychopharm Commandment 7A: Red Flags & Controlled Meds

April 3, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

The DEA has warned pharmacists to watch for Red Flags in controlled prescriptions, and we’ll show you what they are and how to use them therapeutically in practice.

The Other Side of Psych Meds: An Interview with David Healy

March 6, 2023

Chris Aiken, MD

Find out what psychiatry's favorite critic does in his practice.

What We Learned in 2022

January 8, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Top psychiatric findings from the 2022 Carlat Report

Breastfeeding and Psychiatric Medications

December 19, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

The FDA has a new rating system for breastfeeding risks with medications. We look at what that changes for psychotropics.

Pregnancy and PMDD at the Mood Summit

December 5, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

This podcast brings you up to date on how to manage premenstrual dysphoric disorder and safe prescribing during pregnancy.

Sorting Out Bipolar Spectrum Disorders in Children and Adolescents

November 28, 2022

Joshua Feder, MD and Mara Goverman

Bipolar disorder is challenging to diagnose in children and adolescents, yet timely and accurate diagnosis is crucial.

Antidepressants and Bipolar at the Mood Summit

November 21, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Dr. Joe Goldberg gathered the latest evidence on antidepressants in bipolar disorder at the 9th annual Mood Disorders Summit, and we summarize his findings.

EXPERT Q&A

Treatment-Resistant Depression

September 25, 2022

Charles DeBattista, MD

Charles DeBattista, MD

Professor of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA.

Dr. DeBattista has reported receiving research funding from Relmada, Compass, Janssen, Biolite, Myriad, Neurocentia, Beckley, and Sage, and has served as a consultant for Abvie, Sage, and Corcept. This article was reviewed by Dr. Aiken, Editor-in-Chief, who has concluded that there is no evidence of commercial bias in this educational activity.

Charles DeBattista offers tips for working with patients with treatment-resistant depression.

Understanding the Varieties of Depression

September 25, 2022

Ronald Pies, M.D.

Ronald W. Pies, MD

Professor Emeritus of Psychiatry and Lecturer on Bioethics and Humanities, SUNY Upstate Medical University; Clinical Professor of Psychiatry, Tufts University School of Medicine; Editor-in-Chief Emeritus, Psychiatric Times.

Dr. Pies, expert for this educational activity, has disclosed no relevant financial relationship(s) with ineligible companies to disclose.

Depression is not one illness, but how divide it up? Ronald Pies highlights subtypes of
depression worth paying attention to in practice.

To Benzo, or Not to Benzo: An Interview With Carl Salzman

July 18, 2022

Carl Salzman MD, Chris Aiken, MD, and Kellie Newsome, PMHNP

Carl Salzman removes the stigma from the much maligned benzo, reminding us of when they are essential to treatment and when they cause harm. Dr. Salzman is the past chairman of the American Psychiatric Association’s Benzodiazepine Task Force.